Diabetes Clinical Trials in Massachusetts

Showing 381-400 of 534 trials

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

NCT02015806

The aim of this study is to determine whether adherence to oral maintenance medications differs for patients randomized to receive a RxTimerCap, a Take-N-Slide, a standard pillbox, or none of these devices, with the hypothesis that low-touch devices improve adherence over control and that the increase in adherence is agnostic across devices.

Cardiovascular DiseaseDiabetesBreast Cancer+5 more

Brigham and Women's Hospital53,480 participantsStarted Mar 2014

Woonsocket, Rhode Island, United States

COMPLETEDPhase 320 miles

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

NCT01131676

The aim of the present study is to investigate the safety of BI 10773 treatment in patients with Type 2 Diabetes Mellitus and high cardiovascular risk.

Diabetes Mellitus, Type 2

Boehringer Ingelheim7,064 participantsStarted Jul 2010

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +612 more locations

Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Diabetes Trials in Other Cities

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

Telehealth Intervention for Youth With T1DM

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus Patients

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

Other Conditions in Massachusetts